BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2824759)

  • 1. Effects of anagrelide on platelet cAMP levels, cAMP-dependent protein kinase and thrombin-induced Ca++ fluxes.
    Seiler S; Arnold AJ; Grove RI; Fifer CA; Keely SL; Stanton HC
    J Pharmacol Exp Ther; 1987 Nov; 243(2):767-74. PubMed ID: 2824759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-Bromo-1,5-dihydro-3,6-dimethylimidazo[2,1-b]quinazolin-2(3H)- one (Ro 15-2041), a potent antithrombotic agent that selectively inhibits platelet cyclic AMP-phosphodiesterase.
    Muggli R; Tschopp TB; Mittelholzer E; Baumgartner HR
    J Pharmacol Exp Ther; 1985 Oct; 235(1):212-9. PubMed ID: 2995647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
    Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet effects of caffeic acid due to Ca(2+) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation.
    Lee DH; Kim HH; Cho HJ; Bae JS; Yu YB; Park HJ
    J Atheroscler Thromb; 2014; 21(1):23-37. PubMed ID: 24088646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
    Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
    Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of antiplatelet and antithrombotic activity of midazolam in in vitro and in vivo studies.
    Hsiao G; Shen MY; Chou DS; Chang Y; Lee LW; Lin CH; Sheu JR
    Eur J Pharmacol; 2004 Mar; 487(1-3):159-66. PubMed ID: 15033388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imidazoquinoline derivatives: potent inhibitors of platelet cAMP phosphodiesterase which elevate cAMP levels and activate protein kinase in platelets.
    Seiler S; Gillespie E; Arnold AJ; Brassard CL; Meanwell NA; Fleming JS
    Thromb Res; 1991 Apr; 62(1-2):31-42. PubMed ID: 1649498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cyclic AMP in adenosine inhibition of intracellular calcium rise in human platelets. Comparison of adenosine effects on thrombin- and epinephrine-induced platelet stimulation.
    Feoktistov IA; Paul S; Hollister AS; Robertson D; Biaggioni I
    Am J Hypertens; 1992 Jun; 5(6 Pt 2):147S-153S. PubMed ID: 1321639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Aminochromones block human platelet aggregation by inhibiting cyclic AMP-dependent phosphodiesterase leading to reduced platelet phospholipase C activity.
    Benjamin CW; Lin AH; Morris J; Wishka DG; Gorman RR
    J Pharmacol Exp Ther; 1993 Apr; 265(1):457-62. PubMed ID: 7682615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML; Hamm HE
    J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide-derived second messengers 1,2-diacylglycerol and inositol 1,4,5-tris-phosphate.
    Nofer JR; Walter M; Kehrel B; Wierwille S; Tepel M; Seedorf U; Assmann G
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):861-9. PubMed ID: 9633924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toborinone and olprinone, phosphodiesterase III inhibitors, inhibit human platelet aggregation due to the inhibition of both calcium release from intracellular stores and calcium entry.
    Kageyama K; Mizobe T; Nozuchi S; Hiramatsu N; Nakajima Y; Aoki H
    J Anesth; 2004; 18(2):107-12. PubMed ID: 15127258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
    Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
    Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
    Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin-induced increase in intracellular cyclic 3',5'-adenosine monophosphate in human platelets.
    Droller MJ; Wolfe SM
    J Clin Invest; 1972 Dec; 51(12):3094-103. PubMed ID: 4344994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrolinoleate inhibits platelet activation by attenuating calcium mobilization and inducing phosphorylation of vasodilator-stimulated phosphoprotein through elevation of cAMP.
    Coles B; Bloodsworth A; Eiserich JP; Coffey MJ; McLoughlin RM; Giddings JC; Lewis MJ; Haslam RJ; Freeman BA; O'Donnell VB
    J Biol Chem; 2002 Feb; 277(8):5832-40. PubMed ID: 11748216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p-Terphenyl curtisian E inhibits in vitro platelet aggregation via cAMP elevation and VASP phosphorylation.
    Kamruzzaman SM; Yayeh T; Ji HD; Park JY; Kwon YS; Lee IK; Kim S; Oh SH; Kim SD; Roh SS; Yun BS; Rhee MH
    Vascul Pharmacol; 2013; 59(3-4):83-9. PubMed ID: 23872194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin-induced protein phosphorylation in human platelets.
    Lyons RM; Stanford N; Majerus PW
    J Clin Invest; 1975 Oct; 56(4):924-36. PubMed ID: 169298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YD-3, a novel inhibitor of protease-induced platelet activation.
    Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase.
    Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim TH; Lee IK; Cho JY; Park HJ; Kim SK; Yun BS; Rhee MH
    Phytother Res; 2011 Nov; 25(11):1596-603. PubMed ID: 21394810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.